Not exact matches
«Our
study suggests that direct
current stimulation can compensate somewhat for the loss
of dopamine by decreasing the effort the brain has to put into getting its motor neurons to fire,» adds Shadmehr, the
senior author of a report on the research published online in The Journal
of Neuroscience on Sept. 2.
In the
study, published in the
current online edition
of Cancer Letters,
senior author Karine Cohen - Solal, PhD, and colleagues show for the first time that the RUNX2 transcription factor could also serve as a possible treatment target for melanoma.
«Given
current levels
of health care spending, the only way we can create headroom for innovation is to identify and eliminate low - value care,» said Dr. A. Mark Fendrick, director
of the University
of Michigan Center for Value - Based Insurance Design, and the
study's
senior author.
«TWEAK and its signaling receptor, Fn14, have emerged as a fundamental molecular pathway regulating tissue responses after acute tissue injury and in many different contexts
of chronic injury and disease» said Linda Burkly, Ph.D.,
Senior Distinguished Investigator, VP, Biogen, Inc., and co-
senior author on the
current study.
«Historically, there have always been bacterial strain mix - ups in the course
of doing research,» says Paul Keim, executive director
of The Pathogen and Microbiome Institute at Northern Arizona University in Flagstaff and
senior author on the
current study.
«This work suggests that we need to tease out the mechanisms by which COPD may increase lung cancer risk in smokers, and to conduct clinical trials to determine whether treating COPD in former and
current smokers lessens that risk,» said David Christiani, Elkan Blout Professor
of Environmental Genetics at Harvard Chan School and
senior author of the
study.
Because these networks are based on neuroscientists»
current understanding
of how the brain performs object recognition, the success
of the latest networks suggest that neuroscientists have a fairly accurate grasp
of how object recognition works, says James DiCarlo, a professor
of neuroscience and head
of MIT's Department
of Brain and Cognitive Sciences and the
senior author of a paper describing the
study in the Dec. 11 issue
of the journal PLoS Computational Biology.
The
current study did something similar in the spine, turning scar - forming astrocytes into progenitor cells called neuroblasts that regenerated into neurons,» said Dr. Chun - Li Zhang, assistant professor
of molecular biology at UT Southwestern and
senior author of both
studies.
It may also lead to improved therapies to fight sleeping sickness;
current medications used to combat the disease have improved over the past decade but still include an old arsenic - based drug that kills between 5 and 10 percent
of the people receiving treatment, said the
study's
senior author Stephen Hajduk, a professor
of biochemistry and molecular biology in the UGA Franklin College
of Arts and Sciences.
To deliver the higher
currents needed to get the job done, Antal Berényi,
senior author on the new
study and a neuroscientist at the University
of Szeged in Hungary, developed a new TES system.
«Given the alarming trend
of resistance to our
current antimalarial therapies, this is really an exciting finding,» says Dr. Mota, the
senior author of the
study, «and we are already working to develop Torin molecules suitable for clinical trials
of antimalarial activity in humans.»
«We knew that these genes in the Tbx family are important determinants in whether a limb becomes a hind or fore limb,» said Juan Carlos Izpisúa Belmonte, Salk associate professor and
senior author on the
study, which appears in the
current issue
of Nature.
«The
current standard
of care is clearly not sufficient, which highlights the urgent need for new therapeutic approaches,» said Saptarsi Haldar, MD, an associate investigator at Gladstone and
senior author of a new
study featured on the cover
of the scientific journal Science Translational Medicine.
In fact, says Jan A. Staessen, MD, the
senior author of the
study and the head
of the hypertension laboratory at the University
of Leuven, in Belgium, the findings «do not support the
current recommendations
of a generalized and indiscriminate reduction
of [sodium] intake at the population level.»